AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
ARTIVION, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$22.28+0.50 (+2.30%)
Close on Oct 19, 2026
- Market cap
- $1.08B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$19.80 (−47.05%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ARTIVION, INC. grew revenue 16.4% to $471.47M over the twelve months to Jun 30, 2026. Operating income rose 17.4% to $20.64M, moving the operating margin from 4.3% to 4.4%. Free cash flow was -$9.16M, down 219.5% from a year earlier.
Revenue
$471.47M
+16.4% vs. a year earlier
Operating income
$20.64M
+17.4% vs. a year earlier
Free cash flow
-$9.16M
-219.5% vs. a year earlier
EPS, diluted
-$0.07
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.08B
- P/E ratio
- –
- Price to sales
- 2.29
- Price to book
- 2.43
- Dividend yield
- –
- Free cash flow yield
- -0.85%
Fundamentals
- Revenue
- $471.47M
- Net income
- -$3.17M
- EPS, diluted
- -$0.07
- Free cash flow
- -$9.16M
- Book value per share
- $9.18
- Diluted shares
- 49M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$471.47M+16.4% YoY
Gross profit
$303.50M+17.1% YoY
Operating income
$20.64M+17.4% YoY
Net income
-$3.17M
EPS, diluted
-$0.07
Free cash flow
-$9.16M-219.5% YoY
Reported periodTrailing twelve months